{"id":"nas","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nasal dryness"},{"rate":"5-10%","effect":"Nasal irritation"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Cough"},{"rate":"5-10%","effect":"Sore throat"}]},"_chembl":null,"_dailymed":{"setId":"b4136b1f-0618-42f0-a9e6-28a1852a909a","title":"NASAL ALLERGY (TRIAMCINOLONE ACETONIDE) SPRAY, METERED [RITE AID CORPORATION]"},"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Nasacort contains the active ingredient triamcinolone acetonide, which is a synthetic corticosteroid that is used to treat nasal congestion and sinus pressure associated with seasonal allergies and other conditions. It works by reducing inflammation in the nasal passages, which helps to relieve symptoms such as congestion, runny nose, and sneezing.","oneSentence":"Nasacort is a corticosteroid that works by reducing inflammation in the nasal passages.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T02:03:02.452Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal allergic rhinitis"},{"name":"Perennial allergic rhinitis"},{"name":"Chronic idiopathic urticaria"}]},"trialDetails":[{"nctId":"NCT06357806","phase":"NA","title":"The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Beijing 302 Hospital","startDate":"2024-05-17","conditions":"Chronic Hepatitis B","enrollment":45},{"nctId":"NCT05937594","phase":"","title":"MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome","status":"RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2020-01-15","conditions":"Neonatal Opioid Withdrawal Syndrome, Neonatal Abstinence Syndrome","enrollment":50},{"nctId":"NCT04783558","phase":"NA","title":"Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women","status":"ACTIVE_NOT_RECRUITING","sponsor":"Washington State University","startDate":"2024-07-15","conditions":"Neonatal Abstinence Syndrome, Opioid-use Disorder","enrollment":30},{"nctId":"NCT06644417","phase":"PHASE2","title":"Clinical Study of TQA3605 Tablets Combined With Nucleoside (Acid) Analogs (NAs) Drugs Compared With NAs Drugs in the Treatment of Chronic Hepatitis B Virus (HBV) Infection","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2024-11-14","conditions":"HBV Infection With LLV","enrollment":122},{"nctId":"NCT07348679","phase":"NA","title":"Cigarette Filter Study","status":"NOT_YET_RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2026-02-15","conditions":"Smoking ( Cigarette)","enrollment":252},{"nctId":"NCT06733649","phase":"NA","title":"Treatment Education for Perinatal Women and Their Community Support","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-07-06","conditions":"Opioid Dependency","enrollment":80},{"nctId":"NCT03997422","phase":"NA","title":"Hepatic Energy Fluxes in NASH and NAS Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Minnesota","startDate":"2019-07-01","conditions":"NASH - Nonalcoholic Steatohepatitis, NAS, Overweight or Obesity","enrollment":30},{"nctId":"NCT07246889","phase":"PHASE3","title":"Study of AHB-137 in Participants With Chronic Hepatitis B (CHB) Treated With Nucleos(t)Ide Analogues (NAs)(AUSHINE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ausper Biopharma Co., Ltd.","startDate":"2025-08-12","conditions":"Chronic Hepatitis B","enrollment":577},{"nctId":"NCT05961098","phase":"PHASE2","title":"A Study of RBD1016 in CHB Participants","status":"COMPLETED","sponsor":"Suzhou Ribo Life Science Co. Ltd.","startDate":"2023-10-11","conditions":"Chronic Hepatitis b","enrollment":48},{"nctId":"NCT07069569","phase":"PHASE2","title":"A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ausper Biopharma Co., Ltd.","startDate":"2025-05-30","conditions":"Chronic Hepatitis B","enrollment":127},{"nctId":"NCT06706310","phase":"PHASE2","title":"Evaluate TQ-A3334 Combined Nucleoside (Acid) Analogs in the First Treatment/Treatment of Chronic HBV Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2024-12-04","conditions":"Chronic Hepatitis B","enrollment":116},{"nctId":"NCT04896255","phase":"","title":"Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B","status":"RECRUITING","sponsor":"Huashan Hospital","startDate":"2020-09-09","conditions":"Chronic Hepatitis b","enrollment":33000},{"nctId":"NCT06115993","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ausper Biopharma Co., Ltd.","startDate":"2023-08-03","conditions":"Hepatitis B, Chronic","enrollment":129},{"nctId":"NCT06829329","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ausper Biopharma Co., Ltd.","startDate":"2024-12-13","conditions":"Chronic Hepatitis B","enrollment":105},{"nctId":"NCT07183293","phase":"NA","title":"A Study on Peginterferon Alfa-2b Combined With NAs in Compensated HBV Cirrhosis","status":"NOT_YET_RECRUITING","sponsor":"Xiamen Humanity Hospital","startDate":"2025-10","conditions":"HBV-related Liver Cirrhosis","enrollment":30},{"nctId":"NCT05226624","phase":"NA","title":"The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT Program","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2023-10-01","conditions":"Neonatal Abstinence Syndrome","enrollment":240},{"nctId":"NCT05769816","phase":"PHASE2","title":"A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A)","status":"RECRUITING","sponsor":"The Second Affiliated Hospital of Chongqing Medical University","startDate":"2023-10-10","conditions":"Chronic Hepatitis b, Anti-PD-1 Antibody","enrollment":120},{"nctId":"NCT05771402","phase":"PHASE2","title":"A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)","status":"RECRUITING","sponsor":"The Second Affiliated Hospital of Chongqing Medical University","startDate":"2023-10-10","conditions":"Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNα","enrollment":120},{"nctId":"NCT06303986","phase":"","title":"Study to Collect Data for Neonatal Abstinence Syndrome (NAS) and Evaluate the Automated Data Collection Process","status":"ENROLLING_BY_INVITATION","sponsor":"Rekovar Inc.","startDate":"2024-03-18","conditions":"Neonatal Abstinence Syndrome","enrollment":100},{"nctId":"NCT05345990","phase":"PHASE2","title":"Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins","status":"TERMINATED","sponsor":"Hannover Medical School","startDate":"2022-08-15","conditions":"Chronic Hepatitis B","enrollment":13},{"nctId":"NCT05364931","phase":"PHASE2","title":"A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2022-07-14","conditions":"Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis","enrollment":54},{"nctId":"NCT07120750","phase":"","title":"Post-Radical Treatment Antiviral Strategies in HBV-Related Liver Cancer: Impact on Tumor Prognosis","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Third People's Hospital","startDate":"2025-09-01","conditions":"Hepatocellular Carcinoma (HCC), Chronic Hepatitis B","enrollment":332},{"nctId":"NCT07095855","phase":"PHASE3","title":"A Phase III Study to Evaluate the Efficacy and Safety of ZM-H1505R in Patients With CHB","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhimeng Biopharma, Inc.","startDate":"2025-08","conditions":"Chronic Hepatitis B","enrollment":1300},{"nctId":"NCT07079150","phase":"","title":"Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study","status":"RECRUITING","sponsor":"First Affiliated Hospital Xi'an Jiaotong University","startDate":"2025-01-01","conditions":"Hepatitis B, Chronic (CHB), Hepatitis B, Hepatitis B Virus (HBV)","enrollment":1500},{"nctId":"NCT04419857","phase":"NA","title":"A Trial to Determine Weight Gain Benefits of Caloric Supplementation for NAS Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2020-12-04","conditions":"Neonatal Abstinence Syndrome","enrollment":39},{"nctId":"NCT05214118","phase":"NA","title":"Bringing Education Through Technology, Empathic Listening, and Research","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2022-02-02","conditions":"Pregnancy Related","enrollment":29},{"nctId":"NCT06576323","phase":"NA","title":"An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2024-07-01","conditions":"Opioid Use Disorder, Neonatal Abstinence Syndrome","enrollment":50},{"nctId":"NCT06885710","phase":"PHASE1","title":"HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients","status":"RECRUITING","sponsor":"Changhai Hospital","startDate":"2024-12-31","conditions":"Chronic Hepatitis b","enrollment":19},{"nctId":"NCT07071636","phase":"PHASE4","title":"Clinical Efficacy of Pegylated Interferon Alpha-2b Combined With Nucleos(t)Ide Analogues in the Treatment of Chronic Hepatitis B Patients","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Third People's Hospital","startDate":"2025-08-15","conditions":"Metabolic Dysfunction-Associated Steatotic Liver Disease, Chronic Hepatitis B","enrollment":830},{"nctId":"NCT04508348","phase":"NA","title":"Clinical Trial to Decrease Length of Stay in Infants With Neonatal Abstinence Syndrome With an Exclusive Human Milk Diet","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2020-08-31","conditions":"Neonatal Abstinence Syndrome","enrollment":19},{"nctId":"NCT02801331","phase":"NA","title":"Efficacy and Outcomes of a Non-Pharmacological Intervention for Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"Elisabeth B Salisbury","startDate":"2017-03-09","conditions":"Neonatal Abstinence Syndrome","enrollment":208},{"nctId":"NCT05123599","phase":"PHASE1","title":"A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-12-06","conditions":"Hepatitis B, Chronic","enrollment":24},{"nctId":"NCT03396588","phase":"PHASE3","title":"Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain","status":"COMPLETED","sponsor":"Henrietta Bada","startDate":"2017-12-07","conditions":"Neonatal Abstinence Syndrome","enrollment":120},{"nctId":"NCT03725332","phase":"NA","title":"The PATH Home Trial: A Comparative Effectiveness Study of Peripartum Opioid Use Disorder in Rural Kentucky","status":"COMPLETED","sponsor":"Wendy F Hansen","startDate":"2019-03-13","conditions":"Neonatal Abstinence Syndrome","enrollment":269},{"nctId":"NCT05182463","phase":"PHASE4","title":"Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients","status":"RECRUITING","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2022-01-08","conditions":"Hepatitis B, Chronic","enrollment":5000},{"nctId":"NCT06926647","phase":"","title":"A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B","status":"NOT_YET_RECRUITING","sponsor":"Beijing 302 Hospital","startDate":"2025-05-01","conditions":"HBV, Chronic Hepatitis b","enrollment":2000},{"nctId":"NCT06868511","phase":"PHASE3","title":"Neuronavigation-assisted Stereotactic Puncture With Tenecteplase for Acute Intracerebral Hemorrhage","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-04-25","conditions":"Deep Intracerebral Hemorrhage (ICH)","enrollment":732},{"nctId":"NCT04954859","phase":"PHASE2","title":"Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)","status":"RECRUITING","sponsor":"GlaxoSmithKline","startDate":"2021-12-14","conditions":"Hepatitis B","enrollment":450},{"nctId":"NCT03792919","phase":"PHASE4","title":"Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)","status":"RECRUITING","sponsor":"Humanity & Health Medical Group Limited","startDate":"2018-12-01","conditions":"Chronic Hepatitis B","enrollment":2000},{"nctId":"NCT02768844","phase":"NA","title":"Physiology and Therapeutic Management of Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2011-04","conditions":"Neonatal Abstinence Syndrome","enrollment":46},{"nctId":"NCT06874127","phase":"","title":"Non-Invasive Model for Fibrosis Regression in HBV Patients","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2024-02-01","conditions":"Chronic Hepatitis B Virus (HBV) Infection, Liver Fibrosis","enrollment":1100},{"nctId":"NCT03533985","phase":"NA","title":"Effect of Music Therapy on Infants With Neonatal Abstinence Syndrome","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2017-11-01","conditions":"NAS","enrollment":200},{"nctId":"NCT05312645","phase":"PHASE3","title":"Diclofenac Gel in the Treatment of Cervicogenic Headache","status":"WITHDRAWN","sponsor":"Loma Linda University","startDate":"2023-12","conditions":"Cervicogenic Headache","enrollment":""},{"nctId":"NCT04816851","phase":"","title":"Aortic Valve Leaflets Reconstruction (Ozaki Procedure) in Aortic Valve Diseases","status":"COMPLETED","sponsor":"Assiut University","startDate":"2021-03-30","conditions":"Aortic Valve Disease","enrollment":1},{"nctId":"NCT06777173","phase":"NA","title":"Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults","status":"ENROLLING_BY_INVITATION","sponsor":"Beijing Ditan Hospital","startDate":"2023-12-01","conditions":"Chronic Hepatitis b, Immunotherapy","enrollment":180},{"nctId":"NCT05905458","phase":"PHASE2","title":"A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)","status":"COMPLETED","sponsor":"Chengdu Suncadia Medicine Co., Ltd.","startDate":"2023-07-28","conditions":"Chronic Hepatitis B","enrollment":54},{"nctId":"NCT04932512","phase":"PHASE2","title":"A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224","status":"COMPLETED","sponsor":"Ionis Pharmaceuticals, Inc.","startDate":"2021-06-17","conditions":"Steatohepatitis, Nonalcoholic","enrollment":160},{"nctId":"NCT06150014","phase":"PHASE1, PHASE2","title":"A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B","status":"ACTIVE_NOT_RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2023-12-07","conditions":"Chronic Hepatitis b","enrollment":88},{"nctId":"NCT03718104","phase":"","title":"MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy Study","status":"COMPLETED","sponsor":"Boston Medical Center","startDate":"2018-12-01","conditions":"Opioid-use Disorder, Neonatal Abstinence Syndrome, Pregnancy, High Risk","enrollment":46},{"nctId":"NCT06642194","phase":"NA","title":"The Effectiveness of Sunnah on Sleeping on Sleep Quality, Fatigue, Depression and Anxiety Among Patient Undegroing Hemodialysis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universitas Muhammadiyah Yogyakarta","startDate":"2024-05-20","conditions":"Sleep Quality, Fatigue, Anxiety","enrollment":60},{"nctId":"NCT03092011","phase":"PHASE4","title":"Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cooper Health System","startDate":"2018-02-21","conditions":"Neonatal Abstinence Syndrome","enrollment":69},{"nctId":"NCT05254626","phase":"PHASE2","title":"Efficacy and Safety of Dapagliflozin in Patients with Non-alcoholic Steatohepatitis","status":"COMPLETED","sponsor":"Cairo University","startDate":"2022-08-01","conditions":"Non-alcoholic Steatohepatitis","enrollment":100},{"nctId":"NCT06542042","phase":"","title":"Application of Nanopore Adaptive Sequencing","status":"NOT_YET_RECRUITING","sponsor":"Shenzhen Third People's Hospital","startDate":"2024-10-01","conditions":"Liver Transplant Infection","enrollment":100},{"nctId":"NCT05563259","phase":"","title":"Cognitive Assessment and Brain Function Evaluation in Patients With Non-alcoholic Fatty Liver Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Yan Bi","startDate":"2020-05-01","conditions":"Non-Alcoholic Fatty Liver Disease, Cognitive Impairment","enrollment":500},{"nctId":"NCT06457477","phase":"NA","title":"Sequential Combination Therapy With PD-1 Antibody and Peg-IFNα in CHB Patients","status":"RECRUITING","sponsor":"Beijing 302 Hospital","startDate":"2024-06-15","conditions":"Chronic Hepatitis B","enrollment":50},{"nctId":"NCT06368882","phase":"PHASE4","title":"Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）","status":"RECRUITING","sponsor":"First Affiliated Hospital of Wenzhou Medical University","startDate":"2024-01-01","conditions":"Nonalcoholic Fatty Liver Disease, Chronic Hepatitis b","enrollment":1500},{"nctId":"NCT06323681","phase":"NA","title":"Pegylated Interferon α in Previously Interferon-treated CHB（Leading Study）","status":"RECRUITING","sponsor":"Qing XIe","startDate":"2024-02-04","conditions":"Chronic Hepatitis b","enrollment":2016},{"nctId":"NCT04846491","phase":"PHASE3","title":"A Study of Peginterferon Alfa-2b Combined With TDF in Patients With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Xiamen Amoytop Biotech Co., Ltd.","startDate":"2019-12-04","conditions":"Chronic Hepatitis B","enrollment":475},{"nctId":"NCT03291847","phase":"PHASE2","title":"Maternal Buprenorphine-naloxone Treatment and the Infant","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2018-06-01","conditions":"Maternal Opioid Use Disorder, Opioid Exposed Infant","enrollment":42},{"nctId":"NCT04774510","phase":"NA","title":"Optimized C-arm Cone Beam CT for the Endovascular Treatment (EVT) of Acute Stroke","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-01-15","conditions":"Stroke, Acute","enrollment":38},{"nctId":"NCT06206889","phase":"","title":"Nursing Activity Score (Nursing Activities Score-NAS) Verification of Turkish Version","status":"COMPLETED","sponsor":"Samsun University","startDate":"2023-05-05","conditions":"Nurse's Role","enrollment":150},{"nctId":"NCT06097338","phase":"","title":"Quantitative US for Evaluation of Hepatic Steatosis in MAFLD With UDFF","status":"NOT_YET_RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2023-10","conditions":"Fatty Liver Disease, Nonalcoholic","enrollment":200},{"nctId":"NCT06044467","phase":"PHASE1","title":"The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects","status":"COMPLETED","sponsor":"ChemomAb Ltd.","startDate":"2018-12-11","conditions":"Nonalcoholic Fatty Liver Disease","enrollment":16},{"nctId":"NCT06029634","phase":"","title":"Effects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB Patients","status":"COMPLETED","sponsor":"Changhai Hospital","startDate":"2020-07-01","conditions":"Chronic HBV Infection, Drug Withdrawal","enrollment":45},{"nctId":"NCT03134703","phase":"PHASE2","title":"Methadone Demonstration Project With Neonatal Intensive Care Unit Infants Diagnosed With Neonatal Abstinence Syndrome","status":"TERMINATED","sponsor":"Johns Hopkins All Children's Hospital","startDate":"2017-02-27","conditions":"Neonatal Abstinence Syndrome","enrollment":11},{"nctId":"NCT05922306","phase":"EARLY_PHASE1","title":"Efficacy of NA Combined With PEG-IFN-α2b in the Continuous Versus Pulsed Treatment of Patients With Chronic Hepatitis B","status":"RECRUITING","sponsor":"Anhui Medical University","startDate":"2023-07","conditions":"Hepatitis B, Chronic","enrollment":1084},{"nctId":"NCT04455802","phase":"PHASE3","title":"Randomized Control Trial of Buprenorphine vs. Morphine for the Treatment of Neonatal Opioid Withdrawal Syndrome (NOWS)","status":"WITHDRAWN","sponsor":"Women and Infants Hospital of Rhode Island","startDate":"2020-10-01","conditions":"Neonatal Opioid Withdrawal Syndrome","enrollment":""},{"nctId":"NCT05671315","phase":"NA","title":"A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients","status":"RECRUITING","sponsor":"Qing XIe","startDate":"2019-07-03","conditions":"Chronic Hepatitis B, Intermediate to High Risk of HCC","enrollment":267},{"nctId":"NCT02851303","phase":"PHASE4","title":"Morphine Versus Methadone for Opiate Exposed Infants With Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2016-10","conditions":"Neonatal Abstinence Syndrome","enrollment":61},{"nctId":"NCT03771677","phase":"NA","title":"To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs.","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2018-12-01","conditions":"Hepatitis B","enrollment":400},{"nctId":"NCT05792878","phase":"","title":"Study of COVID-19 Infection and Its Clinical Prognosis in Chronic Hepatitis B Patients With Antiviral Therapy","status":"UNKNOWN","sponsor":"Beijing Ditan Hospital","startDate":"2022-09-01","conditions":"Chronic Hepatitis B, COVID-19 Infection","enrollment":600},{"nctId":"NCT03762317","phase":"PHASE4","title":"Clonidine as Adjunct to Morphine for Neonatal Abstinence Syndrome","status":"TERMINATED","sponsor":"Hennepin County Medical Center, Minneapolis","startDate":"2018-04-30","conditions":"Neonatal Abstinence Syndrome","enrollment":10},{"nctId":"NCT05721300","phase":"NA","title":"Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer","status":"UNKNOWN","sponsor":"Zhongshan Hospital (Xiamen), Fudan University","startDate":"2023-02-10","conditions":"Hepatocellular Carcinoma, Chronic Hepatitis B","enrollment":2215},{"nctId":"NCT04179721","phase":"NA","title":"Reducing Behavioral and Psychological Symptoms of Dementia: Hospital Caregivers (Aim 2)","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2019-10-22","conditions":"Alzheimer's Disease and Related Dementias","enrollment":54},{"nctId":"NCT04298853","phase":"PHASE4","title":"Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"Indiana University","startDate":"2020-06-30","conditions":"Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal, Neonatal Opioid Withdrawal Syndrome","enrollment":17},{"nctId":"NCT04867070","phase":"NA","title":"Pain Management in Laparoscopic Living-donor Nephrectomy: The Impact of Erector Spinae Plane Block (ESPB) on Perioperative Period","status":"COMPLETED","sponsor":"Akdeniz University","startDate":"2021-04-27","conditions":"Pain, Postoperative, Donor Site Complication","enrollment":60},{"nctId":"NCT01965704","phase":"PHASE2","title":"Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women","status":"COMPLETED","sponsor":"Stanford University","startDate":"2014-09-09","conditions":"Narcotic Addiction, Neonatal Abstinence Syndrome","enrollment":196},{"nctId":"NCT03881553","phase":"NA","title":"Interventions to Help Infants Recover in the Hospital","status":"TERMINATED","sponsor":"Elisabeth Salisbury, PhD","startDate":"2019-07-19","conditions":"Infant Apnea, Neonatal Abstinence Syndrome, Sleep","enrollment":17},{"nctId":"NCT05357183","phase":"","title":"The Study on Clinical Outcome and Treatment Optimization of Chronic Hepatitis B Patients With Hypoviremia","status":"UNKNOWN","sponsor":"Beijing Ditan Hospital","startDate":"2022-01-01","conditions":"Chronic Hepatitis B","enrollment":1200},{"nctId":"NCT03670160","phase":"PHASE2","title":"Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"University of Tennessee Medical Center","startDate":"2018-10-01","conditions":"Neonatal Abstinence Syndrome","enrollment":25},{"nctId":"NCT02277431","phase":"PHASE2, PHASE3","title":"Probiotic Supplementation Among Adults With Recurrent Gastrointestinal Symptoms","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2014-12","conditions":"Gastrointestinal Symptoms, Bloating, Gas","enrollment":80},{"nctId":"NCT03146806","phase":"PHASE1, PHASE2","title":"Intranasal (NAS) Ketamine for Cancer Pain","status":"COMPLETED","sponsor":"Emory University","startDate":"2017-07-25","conditions":"Cancer, Pain","enrollment":10},{"nctId":"NCT04983563","phase":"NA","title":"Actigraphy and Neonatal Abstinence Syndrome of Hospitalized Newborn in Intensive Care Units","status":"UNKNOWN","sponsor":"University Hospital, Caen","startDate":"2021-03-01","conditions":"Neonatal Abstinence Syndrome","enrollment":50},{"nctId":"NCT03246243","phase":"","title":"Quantitative Assessment of Sucking for Early Diagnosis of Brain Injury in Infants at High Risk","status":"TERMINATED","sponsor":"Boston Children's Hospital","startDate":"2017-03-29","conditions":"Hypoxic-Ischemic Encephalopathy, Hypoglycemia, Neonatal Abstinence Syndrome","enrollment":16},{"nctId":"NCT03977545","phase":"NA","title":"Actigraphy and Neonatal Abstinence Syndrome","status":"UNKNOWN","sponsor":"University Hospital, Caen","startDate":"2019-01-23","conditions":"Neonatal Abstinence Syndrome","enrollment":50},{"nctId":"NCT03890562","phase":"NA","title":"Assessing the Effects of Auricular Acupressure on Newborns With NAS","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2019-09-04","conditions":"Neonatal Abstinence Syndrome","enrollment":12},{"nctId":"NCT03909191","phase":"","title":"Serum HBV RNA Value on Chronic Hepatitis B Virus Infection Manage","status":"COMPLETED","sponsor":"Changhai Hospital","startDate":"2016-02-01","conditions":"Chronic HBV Infection, Drug Withdrawal","enrollment":454},{"nctId":"NCT04611659","phase":"NA","title":"Averting NAS Among Opioid-Using Young Women Receiving MAT Using Buprenorphine","status":"UNKNOWN","sponsor":"Meharry Medical College","startDate":"2020-11","conditions":"Opioid-use Disorder, Contraception, Neonatal Abstinence Syndrome","enrollment":80},{"nctId":"NCT01935635","phase":"PHASE1, PHASE2","title":"A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB","status":"COMPLETED","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2015-01","conditions":"Chronic Hepatitis B","enrollment":400},{"nctId":"NCT04501224","phase":"NA","title":"The Efficacy and Safety of TAF vs Other NAs in Patients With LVL","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2020-08-03","conditions":"Chronic Hepatitis b, Cirrhosis Due to Hepatitis B","enrollment":200},{"nctId":"NCT04133259","phase":"PHASE2","title":"Evaluate the Efficacy and Safety of HLX10 in Chronic Hepatitis B Patients","status":"UNKNOWN","sponsor":"Henlix, Inc","startDate":"2019-12-31","conditions":"Hepatitis B, Chronic","enrollment":44},{"nctId":"NCT04212065","phase":"PHASE4","title":"Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women","status":"WITHDRAWN","sponsor":"Ohio State University","startDate":"2020-02-21","conditions":"Opioid Use Disorder","enrollment":""},{"nctId":"NCT04565262","phase":"PHASE4","title":"Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years","status":"UNKNOWN","sponsor":"Beijing 302 Hospital","startDate":"2020-09","conditions":"HBeAg Positive Chronic Hepatitis B","enrollment":200},{"nctId":"NCT04519359","phase":"NA","title":"Biomarkers Guided Stopping NAs Treatment","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2020-07-06","conditions":"Chronic Hepatitis b","enrollment":195},{"nctId":"NCT01452789","phase":"PHASE3","title":"Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2011-11","conditions":"Neonatal Abstinence Syndrome","enrollment":63},{"nctId":"NCT03973801","phase":"NA","title":"Feasibility of Auricular Acupressure as an Adjunct Treatment for Neonatal Abstinence Syndrome (NAS)","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2019-08-19","conditions":"Neonatal Abstinence Syndrome, Withdrawal","enrollment":12},{"nctId":"NCT03801798","phase":"PHASE2","title":"A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients","status":"UNKNOWN","sponsor":"Green Cross Corporation","startDate":"2019-02-11","conditions":"Hepatitis B","enrollment":42},{"nctId":"NCT02787304","phase":"PHASE2","title":"Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)","status":"TERMINATED","sponsor":"Mirum Pharmaceuticals, Inc.","startDate":"2016-10-24","conditions":"Non-Alcoholic Steatohepatitis","enrollment":197},{"nctId":"NCT02195518","phase":"PHASE4","title":"Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-03-18","conditions":"Hepatitis B, Chronic","enrollment":213},{"nctId":"NCT01958476","phase":"PHASE3","title":"Improving Outcomes in Neonatal Abstinence Syndrome","status":"COMPLETED","sponsor":"Tufts Medical Center","startDate":"2013-09","conditions":"Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal","enrollment":117}],"_emaApprovals":[],"_faersSignals":[{"count":14,"reaction":"DEATH"},{"count":4,"reaction":"DIARRHOEA"},{"count":4,"reaction":"PNEUMONIA"},{"count":3,"reaction":"ARTHRALGIA"},{"count":3,"reaction":"FATIGUE"},{"count":3,"reaction":"NAUSEA"},{"count":2,"reaction":"ABDOMINAL PAIN"},{"count":2,"reaction":"BACK PAIN"},{"count":2,"reaction":"BREAST CANCER"},{"count":2,"reaction":"BRONCHITIS"}],"_approvalHistory":[],"publicationCount":8418,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ETV/TDF/TAF"],"phase":"marketed","status":"active","brandName":"NAs","genericName":"NAs","companyName":"Beijing 302 Hospital","companyId":"beijing-302-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Nasacort is a corticosteroid that works by reducing inflammation in the nasal passages. Used for Seasonal allergic rhinitis, Perennial allergic rhinitis, Chronic idiopathic urticaria.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}